Amryt gets FDA orphan drug designation for Mycapssa for carcinoid syndrome

Amryt, a commercial-stage biopharma company, has secured orphan drug designation for Mycapssa (octreotide capsules) from the US Food and Drug Administration (FDA) for the treatment ... Read More